Abstract:The Staphylococcus sp . are a dominant part of the human skin microbiome and present across the body. Staphylococcus epidermidis is a ubiquitous skin commensal, while S . aureus is thought to colonize at least 30% of the population. S . aureus are not only colonizers but a leading cause of skin and soft tissue infections and a critical healthcare concern. To understand how healthy human skin may differentiate commensal bacteria, such as S . epidermidis , from the potential pathogen methicillin-resistant S . aureus (MRSA), we use ex vivo human skin models that allow us to study this host-bacterial interaction in the most clinically relevant environment. Our work highlights the role of the outer stratum corneum as a protective physical barrier against invasion by colonizing Staphylococci. We show how the structural cells of the skin can internalize and respond to different Staphylococci with increasing sensitivity. In intact human skin, a discriminatory IL-1β response was identified, while disruption of the protective stratum corneum triggered an increased and more diverse immune response. We identified and localized tissue resident Langerhans cells (LCs) as a potential source of IL-1β and go on to show a dose-dependent response of MUTZ-LCs to S . aureus but not S . epidermidis . This suggests an important role of LCs in sensing and discriminating between bacteria in healthy human skin, particularly in intact skin and provides a detailed snapshot of how human skin differentiates between friend and potential foe. With the rise in antibiotic resistance, understanding the innate immune response of healthy skin may help us find ways to enhance or manipulate these natural defenses to prevent invasive infection. How healthy human skin can differentiate between commensal bacteria that live harmoniously on our skin and those bacteria that have the potential to cause invasive infection, is of great interest. Here we use ex vivo human skin models to show how the outer layer of human skin resists bacterial invasion and that disruption of this layer leads to increased infection and inflammation. We show how colonization of both intact and disrupted skin by Staphylococcus aureus causes an increased IL-1β signaling compared to the commensal S . epidermidis . We show that tissue resident Langerhans cells are well positioned throughout the skin epidermis and that MUTZ-LCs can differentiate commensal from pathogen via IL-1β. This work identifies one of the subtle, yet effective, pathways by which human skin differentiates commensals and pathogens. Understanding these mechanisms could lead to potential new treatment and prevention targets, mechanisms by which we can enhance innate immunity.

Selective Antimicrobial Action Is Provided by Phenol-Soluble Modulins Derived from Staphylococcus epidermidis, a Normal Resident of the Skin

Staphylococcus Epidermidis Antimicrobial Delta-Toxin (Phenol-Soluble Modulin-Gamma) Cooperates with Host Antimicrobial Peptides to Kill Group A Streptococcus.

Production of an attenuated phenol-soluble modulin variant unique to the MRSA clonal complex 30 increases severity of bloodstream infection.

Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections.

Cyclic-di-GMP Stimulates Keratinocyte Innate Immune Responses and Attenuates Methicillin-Resistant Staphylococcus Aureus Colonization in a Murine Skin Wound Infection Model

Innate antimicrobial peptide protects the skin from invasive bacterial infection

The Human Anionic Antimicrobial Peptide Dermcidin Induces Proteolytic Defence Mechanisms in Staphylococci.

Antimicrobial Peptides: Effectors of Innate Immunity in the Skin

A Novel Lipopeptide From Skin Commensal Activates Tlr2/Cd36-P38 Mapk Signaling To Increase Antibacterial Defense Against Bacterial Infection

Antimicrobial Peptides (AMPs): New Perspectives on Their Function in Dermatological Diseases

Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids.

Competition between skin antimicrobial peptides and commensal bacteria in type 2 inflammation enables survival of S. aureus

Small proline-rich proteins (SPRRs) are epidermally produced antimicrobial proteins that defend the cutaneous barrier by direct bacterial membrane disruption

The antimicrobial peptide-sensing system aps of Staphylococcus aureus.

Biological Activities of Cationicity-Enhanced and Hydrophobicity-Optimized Analogues of an Antimicrobial Peptide, Dermaseptin-PS3, from the Skin Secretion of Phyllomedusa sauvagii

Gram-positive Three-Component Antimicrobial Peptide-Sensing System

Structure-activity Relationship of an Antimicrobial Peptide, Phylloseptin-PHa: Balance of Hydrophobicity and Charge Determines the Selectivity of Bioactivities

Susceptibility of clinical Staphylococcus aureus isolates to innate defense antimicrobial peptides

Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides

Tissue resident cells differentiate S . aureus from S . epidermidis via IL-1β following barrier disruption in healthy human skin

Bacterial soft tissue infection in psoriasis despite induction of epidermal antimicrobial peptides